Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.
about
cAMP-PKA-CaMKII signaling pathway is involved in aggravated cardiotoxicity during Fuzi and Beimu Combination Treatment of Experimental Pulmonary HypertensionAdvances in receptor conformation research: the quest for functionally selective conformations focusing on the β2-adrenoceptorAdrenergic Receptors in Individual Ventricular Myocytes: The Beta-1 and Alpha-1B Are in All Cells, the Alpha-1A Is in a Subpopulation, and the Beta-2 and Beta-3 Are Mostly Absent.Insulin and β Adrenergic Receptor Signaling: Crosstalk in Heart.Alpha2-adrenoceptors in adrenomedullary chromaffin cells: functional role and pathophysiological implications.A New Pathway for Sympathetic Cardioprotection in Heart Failure.Chinese innovation in cardiovascular drug discovery.Role of Beta-adrenergic Receptors and Sirtuin Signaling in the Heart During Aging, Heart Failure, and Adaptation to Stress.Stage‑dependent changes of β2‑adrenergic receptor signaling in right ventricular remodeling in monocrotaline‑induced pulmonary arterial hypertension.Correspondence: Reply to 'Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury'.IL-18 cleavage triggers cardiac inflammation and fibrosis upon β-adrenergic insult.Ginseng Compatibility Environment Attenuates Toxicity and Keeps Efficacy in Cor Pulmonale Treated by Fuzi Beimu Incompatibility Through the Coordinated Crosstalk of PKA and Epac Signaling Pathways.Recent Update on the Pharmacological Effects and Mechanisms of DihydromyricetinAlteration of β-Adrenoceptor Signaling in Left Ventricle of Acute Phase Takotsubo Syndrome: a Human StudyFuzi and Banxia Combination, Eighteen Antagonisms in Chinese Medicine, Aggravates Adriamycin-Induced Cardiomyopathy Associated with PKA/2AR-Gs Signaling
P2860
Q28822014-E4812DE4-A35C-4984-9D1F-B5FE7CEF2D3FQ36342155-1E17BA30-1C15-4111-A01B-B17916AEA1D0Q38951165-2F3B353B-B487-40A4-B904-C045DF982C05Q39159635-9F3DE7CA-1E11-4EEF-8FF2-856A1A953600Q43061548-43129592-260E-4B1F-937A-E3F72B5312B9Q43115266-F50C419E-32A8-4EC1-84B6-DA4BBA9EB53CQ43145398-ECA346C7-8362-4BE8-9CB2-5E1F3670C3EBQ46276226-9AAFA41A-C322-40CC-83A9-9528EF3B229EQ47824028-1C48B442-043F-4477-B58C-70824D425DC9Q50130085-975A9A5B-A8E2-47C6-842F-E0273A14094CQ52768604-9C279F9D-FF8A-4859-A977-1592D6061C83Q55497267-5AB2E81E-A09D-4F90-9B8C-A15765CFA3EDQ58556599-657D626C-E961-4257-94CC-493147456FD9Q58708269-67828D78-E0A5-4FD4-B293-F7A9A2A5A737Q58766694-8DA9EC85-0854-421F-9155-92AA8A20D520
P2860
Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.
@ast
Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.
@en
type
label
Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.
@ast
Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.
@en
prefLabel
Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.
@ast
Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.
@en
P2093
P2860
P356
P1476
Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.
@en
P2093
Rui-Ping Xiao
Weizhong Zhu
P2860
P304
P356
10.1111/BPH.12965
P407
P577
2014-10-08T00:00:00Z